A New Zealand blood cancer patient who was forced to leave his children behind and make a last chance dash to Australia to access funded drugs has now been given a cutting edge transplant that is not publicly available here. Tawhai Reti, who has myeloma, had exhausted all treatment options in NZ. Earlier this year he moved to Australia without his family to access the lifesaving drug Daratumamab, which isn't funded here. It worked so well he has now been given CAR-T cell therapy, which could put him into remission indefinitely. Tawhai and Lani Reti spoke to Lisa Owen.